Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics

Read full text Summarise with VIRAT
Authors: Tengyue Li, Wanqi Mi, Huarui Yan, Yining Ma, Han Jiang, Xiaoxu Yang, Yunpeng Zhang, Congxue Hu
Cited by: 0
References: 99

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Glioblastoma (GBM) is characterized by pronounced tumor heterogeneity and a complex immune microenvironment, contributing to poor patient survival outcomes. In this study, we comprehensively dissected the tumor microenvironment (TME) and uncovered potential molecular mechanisms by integrating single-cell, bulk, and spatial transcriptomic data. Hallmarks of malignancy and cell cycle regulatory pathways were consistently enriched across these modalities, promoting tumor cell proliferation and progression. Using a machine learning algorithm, we identified seven hallmark-related prognostic signatures (HMsig), namely AEBP1, ASF1A, PRPS1, DCC, OPHN1, IL13RA2, and HDAC5-whose predictive importance was validated through SHAP analysis. Ligand-receptor (LR) interaction analysis further revealed that interactions involving OPHN1 were associated with poorer prognosis. Along the pseudotime trajectory of T cell differentiation, immune checkpoint genes (ICGs) LAG3, PDCD1, and HAVCR2 were substantially upregulated. Notably, synergistic transcriptional regulation between tumor-related HMsig genes and ICGs in T cells was identified as a key factor influencing patient survival. Spatial transcriptomic analysis demonstrated the existence of synergistic gene interactions, deciphering the immunomodulatory functions of GBM biomarkers within the TME.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Single-cell and spatial transcriptomics

Publication details

Journal / source
GigaScience
Volume
15
Publication date
21 January 2026
Language
EN